Cargando…

Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer

Muscle-invasive bladder cancer (MIBC) is a heterogeneous disease that often recurs despite aggressive treatment with neoadjuvant chemotherapy and (radical) cystectomy. Basal and luminal molecular subtypes have been identified that are linked to clinical characteristics and have differential sensitiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Vos, K. E., Vis, D. J., Nevedomskaya, E., Kim, Y., Choi, W., McConkey, D., Wessels, L. F. A., van Rhijn, B. W. G., Zwart, W., van der Heijden, M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331601/ https://www.ncbi.nlm.nih.gov/pubmed/32616859 http://dx.doi.org/10.1038/s41598-020-67850-5

Ejemplares similares

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
por: Patel, K. M., et al.
Publicado: (2017)

Genome-wide epigenetic profiling of breast cancer tumors treated with aromatase inhibitors
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2014)

Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
por: Ochoa, Andrea E., et al.
Publicado: (2016)

Intrinsic subtypes and bladder cancer metastasis
por: McConkey, David J., et al.
Publicado: (2016)

Update on bladder cancer molecular subtypes
por: Fong, Megan Hoi Yan, et al.
Publicado: (2020)

Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer
por: van Kessel, Kim E.M., et al.
Publicado: (2016)

Demarcating the boundary conditions of memory reconsolidation: An unsuccessful replication
por: Stemerding, Lotte E., et al.
Publicado: (2022)

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
por: Hinsenveld, F. J., et al.
Publicado: (2021)

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis
por: de Jong, Joep J., et al.
Publicado: (2019)

Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities
por: Yaden, David B, et al.
Publicado: (2021)

The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients
por: van Straten, Christine G. J. I., et al.
Publicado: (2023)

Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2015)

Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
por: Beije, N., et al.
Publicado: (2022)

Pigmentary Demarcation Lines in Pregnancy
por: Chandran, Veena, et al.
Publicado: (2016)

Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer
por: Brummelhuis, Iris S. G., et al.
Publicado: (2021)

The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition
por: van Dorp, Jeroen, et al.
Publicado: (2023)

Androgen receptor profiling predicts prostate cancer outcome
por: Stelloo, Suzan, et al.
Publicado: (2015)

p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers
por: Choi, Woonyoung, et al.
Publicado: (2012)

Body mass index and waist circumference in relation to risk of recurrence and progression after non‐muscle invasive bladder cancer
por: van Zutphen, Moniek, et al.
Publicado: (2023)

Type B pigmentary demarcation lines
por: Gupta, Lalit Kumar, et al.
Publicado: (2016)

Science, Values, and the New Demarcation Problem
por: Resnik, David B., et al.
Publicado: (2023)

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
por: Kompier, Lucie C., et al.
Publicado: (2010)

Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands
por: Reesink, Daan J., et al.
Publicado: (2020)

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
por: Stockem, C.F., et al.
Publicado: (2023)

Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
por: Pagliarulo, Fabio, et al.
Publicado: (2022)

A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer
por: Palit, Sander A. L., et al.
Publicado: (2021)

Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the ‘trials within cohorts’ study ProBCI
por: Richters, Anke, et al.
Publicado: (2021)

Organoid culture of bladder cancer cells
por: Yoshida, Takahiro, et al.
Publicado: (2018)

A systematic review on mutation markers for bladder cancer diagnosis in urine
por: Hentschel, Anouk E., et al.
Publicado: (2020)

Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection
por: Beyranvand Nejad, Elham, et al.
Publicado: (2019)

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
por: Dadhania, Vipulkumar, et al.
Publicado: (2016)

Long-term stability of laser-demarcated macula-sparing rhegmatogenous retinal detachments
por: Lin, James, et al.
Publicado: (2019)

Fast semi-automated lesion demarcation in stroke
por: de Haan, Bianca, et al.
Publicado: (2015)

Technique for tailoring complex demarcation in lung segmentectomy
por: Wang, Jun, et al.
Publicado: (2018)

Demarcating the membrane damage for the extraction of functional mitochondria
por: Rahman, Md Habibur, et al.
Publicado: (2018)

Photoplethysmography for demarcation of cutaneous squamous cell carcinoma
por: Rasmussen, Simon Mylius, et al.
Publicado: (2021)

Multiple Demarcated Cutaneous Lesions: A Quiz
por: SINIKUMPU, Suvi-Päivikki, et al.
Publicado: (2020)

Sharply demarcated erythematous plaque of the bilateral thighs
por: Han, Jane J., et al.
Publicado: (2022)

Thermodynamic basis for the demarcation of Arctic and alpine treelines
por: Martin, Meredith Richardson, et al.
Publicado: (2022)

Pigmentary Demarcation Lines During Pregnancy With Erythema
por: Navea, Oscar V, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0lc4kv2nle6p25m6umiujf4fom